Anna Maria Buehler
5PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 11, 2024
Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study.Daniele Assad Suzuki, Alessandra Menezes Morelle, Mayana Lopes de Brito
|Dec 14, 2022
Effect of ribociclib on productivity losses due to breast cancer in young women in Brazil.Anna Maria Buehler, Pierre-Alexandre Dionne, David Chandiwana
|Nov 07, 2022
Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2- advanced breast cancer: a Brazilian public health care system perspective.Daniela Dornelles Rosa, Carlos Alberto da Silva Magliano, Sergio D Simon
|May 05, 2021
Cost-effectiveness of ribociclib plus letrozole versus palbociclib plus letrozole or letrozole as monotherapy in first-line treatment of postmenopausal women with HR+/HER2- locally advanced or metastatic breast cancer: a Brazilian private payer perspective.Anna Maria Buehler, Gabriela Castilho, Pierre-Alexandre Dionne
|Apr 18, 2019
Rational use of diagnostic tests for clinical decision making.Anna Maria Buehler, Bruna de Oliveira Ascef, Haliton Alves de Oliveira Júnior
Pageof 1
Frequent Collaborators
1 joint publications
Bruna de Oliveira Ascef
1 joint publications
Haliton Alves de Oliveira Júnior
1 joint publications
Cleusa Pinheiro Ferri
1 joint publications
Jefferson Gomes Fernandes
1 joint publications
Tomás Reinert
1 joint publications
Pierre-Alexandre Dionne
1 joint publications
David Chandiwana
1 joint publications
Purnima Pathak
1 joint publications
Ebuwa Igho-Osagie
1 joint publications
Daniele Assad Suzuki
